lomustine and melphalan

lomustine has been researched along with melphalan in 80 studies

Research

Studies (80)

Timeframe	Studies, this research(%)	All Research%
pre-1990	37 (46.25)	18.7374
1990's	17 (21.25)	18.2507
2000's	10 (12.50)	29.6817
2010's	15 (18.75)	24.3611
2020's	1 (1.25)	2.80

Authors

Authors	Studies
Balzarini, J; Das, U; De Clercq, E; Dimmock, JR; Kawase, M; Lorand, T; Perjési, P; Rozmer, Z; Sakagami, H; Stables, JP	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
McIntyre, OR	1
Hansen, HH; Hansen, M; Mouridsen, H; Osterlind, K; Palshof, T	1
Bliss, JM; Gore, ME; Lakhani, S; McElwain, TJ; Perren, TJ; Selby, P	1
Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, JJ; Merke, DP; Myers, J; Straus, DJ; Yahalom, J	1
Grabowska, S; Morelowska, M; Piotrowski, L	1
Siemann, DW	2
Koziner, B; Zori Comba, A	1
Straus, DJ	1
Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, J; Lee, BJ; Merke, D; Myers, J; Nisce, LZ; Straus, DJ	1
Ahrenberg, P; Ala-Harja, K; Almqvist, A; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Jouppila, J; Kilpi, H; Palva, IP	1
Wang, QL	1
Bernasconi, C	1
Brunner, K; Coleman, M; Cooper, MR; Cornwell, GG; Glowienka, LP; Henderson, E; Kochwa, S; McIntyre, OR; Pajak, TF; Rafla, S	1
Antman, KH; Ryan, LM; Siegel, RD	1
Bercowitz, H; Chriqui-Zeira, E; Katz-Gross, A; Kedar, E	1
Ahrenberg, P; Ala-Harja, K; Almqvist, A; Apajalahti, J; Hallman, H; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Palva, IP	1
Háber, J; Klener, P; Kolesková, E; Setková, O	1
Bosanquet, AG	1
Ozhiganov, EL; Platinskiĭ, LV; Sokolova, VD	1
Donaldson, J; Morgan, JE; Talbot, K; Twentyman, PR; Workman, P; Wright, KA	1
Adams, K; Peacock, JH; Stephens, TC	1
Bleehen, NM; Honess, DJ	1
Clarkson, BD; Koziner, B; Lee, BJ; Myers, J; Straus, DJ	1
Arlin, Z; Gee, T; Kempin, S; Koziner, B; Lee, BJ; McCormick, B; Mertelsmann, R; Myers, J; Nisce, LZ; Straus, DJ	1
Bierling, P; Brun, B; Cordonnier, C; Dreyfus, B; Farcet, JP; Feuilhade, F; Kuentz, M; Man, NG; Reyes, F; Rochant, H; Vernant, JP	1
Kehrberg, G; Moldenhauer, H; Rose, H; Saul, G; Wolf, G	1
Twentyman, PR	1
Brown, DM; Brown, JM; Hirst, DG; Horsman, MR	1
Dieckman, J; Medoff, G; Tolen, S; Valeriote, F	1
Deshayes, P; Grobois, B; Le Loët, X; Menard, JF; Monconduit, M; Piguet, H; Prevost, E; Tanguy, A	1
Reeve, JG; Twentyman, PR; Wright, KA	1
Twentyman, PR; Workman, P	1
Jones, AC; Peckham, MJ; Stratford, IJ; Wilson, PA	1
Joiner, MC; Steel, GG; Stephens, TC	1
Twentyman, P; Workman, P	1
Brunner, K; Cooper, MR; Cornwell, GG; Cuttner, J; Glowienka, LP; Haurani, FI; Henderson, E; Kochwa, S; Kyle, RA; McIntyre, OR; Pajak, TF; Rafla, S; Silver, RT	1
Schmidt, JD	1
Lishner, M; Slingerland, J; Sutcliffe, SB; Theresa, C	1
Alessandrino, EP; Astori, C; Bernasconi, P; Brusamolino, E; Canevari, A; Castelli, G; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G	1
Bernabeu Esclapez, A; Canteras Jordana, M; García Reverte, JM; Muñoz Ramos, J; Vicente Ortega, V	1
Badal, MD; Bezanilla, JL; Castel, V; Llombart, A; Melero, C; Mulet, J; Ruiz-Jiménez, JI; Sánchez de Toledo, J	1
Ardiet, C; Lind, MJ	1
Holománová, D; Lipsic, T; Mikulecký, M; Mistrík, M; Sakalová, A; Steruská, M	1
Ala-Harja, K; Almqvist, A; Elonen, E; Hallman, H; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Jouppila, J; Palva, IP	1
Chastang, C; Fabre, C; Lebeau, B; Massin, F; Muir, JF; Vincent, J	1
Rodriguez-Vicente, J; Vicente-Ortega, V	1
Canteras-Jordana, M; Rodriguez-Vicente, J; Vicente-Ortega, V	1
Bass, G; Bloxham, D; Gandhi, MK; Jestice, K; Marcus, RE; Scott, MA	1
Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D	1
Aquilina, G; Bignami, M; Colussi, C; Crescenzi, M; Fiumicino, S; Leonetti, C; Martinelli, S	1
Angrilli, F; Ascari, E; Bertè, R; Broglia, C; Cavanna, L; Di Renzo, N; Ghirardelli, ML; Gobbi, PG; Iannitto, E; Molica, S; Petrilli, MP	1
Benboubker, L; Colombat, P; Dugay, J; Gauvain, JB; Goupille, P; Linassier, C; Lucas, V; Luthier, F; Maigre, M; Rodon, P	1
Alietti, A; Baldini, L; Colombi, M; Guffanti, A; Latargia, ML; Maiolo, AT; Vener, C	1
Bock, PR; Chabronová, I; Dedík, L; Gazová, S; Hanisch, J; Holomanova, D; Hrubisko, M; Mistrík, M; Sakalová, A; Schiess, W	1
Angelucci, E; Baldini, L; Bordonaro, R; Broglia, C; Cavanna, L; Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Liberati, M; Merli, F; Pavone, V; Santini, G; Stelitano, C; Vitolo, U	1
Cheng, S; Evans, WK; Shepherd, FA; Stys-Norman, D	1
Diehl, V; Evens, AM; Hutchings, M	1
Delashaw, JB; Doolittle, ND; Gahramanov, S; Guillaume, DJ; Hedrick, NA; Neuwelt, EA	1
Castellano, A; De Ioris, MA; De Pasquale, MD; De Vito, R; Donfrancesco, A; Garganese, MC; Ilari, I; Inserra, A; Jenkner, A; Locatelli, F; Natali, G; Ravà, L	1
Fukumoto, S; Hanazono, K; Higuchi, S; Hori, Y; Kawasaki, N; Sasaki, T; Temma, K; Uchide, T	1
Dehghani, M; Haghighinejad, H; Mohamadian, M; Nourani, H; Ramzi, M; Vojdani, R; Zakerinia, M	1
Atalla, A; Borges dos Santos, K; Hallack Neto, AE	1
Atalla, A; Costa, LJ; dos Santos, KB; Hallack-Neto, AE; Pereira, J	1
Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C	1
Gore, A; Gupta, A; Jain, R; Jeevangi, N; Kannan, S; Khattry, N; Nair, R; Saikia, T; Thippeswamy, R	1
Ardeshna, KM; Foley, M; Kothari, J; Lambert, J; Linch, DC; Mackenzie, S; Morris, E; Peggs, KS; Thomson, K; Virchis, AE	1
Boostrom, BO; DeRegis, CJ; Freeman, K; Moore, AS; Robat, C; Thamm, DH	1
Kelsey, P; Kirkland, K; Lambert, J; Malladi, R; Morley, N; Paul, R; Pearce, R; Peniket, A; Perry, J; Snowden, JA	1

Reviews

13 review(s) available for lomustine and melphalan

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Current concepts in cancer. Multiple myeloma. The New England journal of medicine, 1979, Jul-26, Volume: 301, Issue:4 Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunoglobulins; Lomustine; Melphalan; Multiple Myeloma; Neoplasm Staging; Plasmapheresis; Prednisone; Risk; Sodium Fluoride; Uremia	1979
[Rescue treatment in Hodgkin's disease]. Sangre, 1987, Volume: 32, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine	1987
Treatment of advanced Hodgkin's disease. Hematology/oncology clinics of North America, 1989, Volume: 3, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine	1989
Etoposide: fifteen years experience. Bone marrow transplantation, 1989, Volume: 4 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Lomustine; Melphalan; Mitoxantrone	1989
Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents. Cancer chemotherapy and pharmacology, 1985, Volume: 14, Issue:2 Topics: Alkylation; Antineoplastic Agents; Carmustine; Chlorambucil; Colony-Forming Units Assay; Cyclophosphamide; Drug Storage; Hydrogen-Ion Concentration; Lomustine; Mathematics; Melphalan; Nimustine; Nitrosourea Compounds; Solutions; Temperature; Tumor Stem Cell Assay	1985
[Chemotherapy of cancer of the large intestine]. Sovetskaia meditsina, 1985, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Colonic Neoplasms; Drug Evaluation; Fluorouracil; Humans; Lomustine; Melphalan; Methotrexate; Rectal Neoplasms; Semustine; Vincristine	1985
[Intensification of cytostatic action by radiosensitizers--a review of the present status of chemosensitization]. Radiobiologia, radiotherapia, 1984, Volume: 25, Issue:2 Topics: Alkylating Agents; Animals; Antineoplastic Agents; Chlorambucil; Cisplatin; Cricetinae; Cyclophosphamide; Doxorubicin; Etanidazole; Lomustine; Melphalan; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents	1984
Modification of chemotherapy by nitroimidazoles. International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:9 Topics: Animals; Antineoplastic Agents; Cyclophosphamide; DNA Repair; Drug Synergism; Glutathione; Lomustine; Melphalan; Mice; Misonidazole; Neoplasms; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Time Factors	1984
Pharmacokinetics of alkylating agents. Cancer surveys, 1993, Volume: 17 Topics: Alkylating Agents; Carmustine; Chlorambucil; Cyclophosphamide; Humans; Ifosfamide; Lomustine; Melphalan; Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Thiotepa	1993
Multiple myeloma in elderly patients: presenting features and outcome. European journal of haematology, 2001, Volume: 66, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Comorbidity; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; France; Humans; Interferon-alpha; Life Tables; Lomustine; Male; Melphalan; Multiple Myeloma; Myeloma Proteins; Neoplasm Staging; Paraneoplastic Syndromes; Prednimustine; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine	2001
Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:4 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials, Phase III as Topic; Etoposide; Female; Humans; Infusions, Intravenous; Lomustine; Lung Neoplasms; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ontario; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Topotecan	2007
Treatment of Hodgkin lymphoma: the past, present, and future. Nature clinical practice. Oncology, 2008, Volume: 5, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine	2008

Trials

20 trial(s) available for lomustine and melphalan

Article	Year
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematocrit; Hodgkin Disease; Humans; Lomustine; Lymphatic Metastasis; Male; Mechlorethamine; Melphalan; Middle Aged; Models, Biological; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Analysis; Vinblastine; Vincristine; Vindesine	1990
Combination chemotherapy MOCCA in resistant and relapsing multiple myeloma. Finnish Leukaemia Group. European journal of haematology, 1992, Volume: 48, Issue:1 Topics: Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin Light Chains; Lomustine; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasm Staging; Recurrence; Treatment Outcome; Vincristine	1992
Treatment of advanced Hodgkin's disease. Hematology/oncology clinics of North America, 1989, Volume: 3, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine	1989
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 117 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine	1989
Treatment of multiple myeloma in old patients. Finnish Leukaemia Group. European journal of haematology, 1989, Volume: 43, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lomustine; Melphalan; Methylprednisolone; Multiple Myeloma; Vincristine	1989
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Lomustine; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Random Allocation; Vincristine	1988
Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone; a randomised multicentre trial. Finnish Leukaemia Group. European journal of haematology, 1987, Volume: 38, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Immunoglobulins; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prednisone; Vincristine	1987
Aggressive combination chemotherapy in multiple myeloma. A multicentre trial. Finnish Leukaemia Group. Scandinavian journal of haematology, 1985, Volume: 35, Issue:2 Topics: Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prognosis; Vincristine	1985
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations. The American journal of medicine, 1984, Volume: 76, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine	1984
Treatment comparisons in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults. British journal of cancer, 1980, Volume: 42, Issue:6 Topics: Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lomustine; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Prognosis; Uremia	1980
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience. Cancer, 1982, Nov-01, Volume: 50, Issue:9 Topics: Antineoplastic Agents; Carmustine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Random Allocation; Thrombocytopenia; Vincristine	1982
Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. Medical and pediatric oncology, 1995, Volume: 24, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Infant; Lomustine; Male; Melphalan; Neuroblastoma; Remission Induction; Treatment Outcome; Vindesine	1995
Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia Group. European journal of haematology, 1993, Volume: 51, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Leukemia, Myeloid, Acute; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Vincristine	1993
No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy. Results from a randomized clinical trial of 303 patients. The "Petites Cellules" Group. Cancer, 1993, Mar-01, Volume: 71, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Melphalan; Middle Aged; Platelet Aggregation; Prednisone; Survival Rate	1993
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease. Haematologica, 2000, Volume: 85, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2000
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma. Leukemia & lymphoma, 2000, Volume: 40, Issue:1-2 Topics: Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Humans; Lomustine; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2000
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2005
Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study. Neurosurgery, 2010, Volume: 66, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Cross-Linking Reagents; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Injections, Intra-Arterial; Lomustine; Male; Melphalan; Middle Aged; Oligodendroglioma; Osmotic Pressure; Procarbazine; Temozolomide; Vincristine; Young Adult	2010
Autologous noncryopreserved hematopoietic stem cell transplant with CEAM as a modified conditioning regimen in patients with Hodgkin lymphoma: a single-center experience with a new protocol. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2012, Volume: 10, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cryopreservation; Cytarabine; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Male; Melphalan; Middle Aged; Prognosis; Recurrence; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult	2012
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Apr-10, Volume: 34, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2016

Other Studies

48 other study(ies) available for lomustine and melphalan

Article	Year
Design, synthesis and antiproliferative activity of some 3-benzylidene-2,3-dihydro-1-benzopyran-4-ones which display selective toxicity for malignant cells. European journal of medicinal chemistry, 2008, Volume: 43, Issue:4 Topics: Animals; Antineoplastic Agents; Benzopyrans; Cell Survival; Drug Design; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Injections, Intraperitoneal; Leukemia L1210; Mice; Models, Molecular; Molecular Structure; Neoplasms; Neurons; Structure-Activity Relationship; Survival Rate; T-Lymphocytes; Tumor Cells, Cultured	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations. European journal of medicinal chemistry, 2010, Volume: 45, Issue:4 Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancer. Cancer treatment reports, 1977, Volume: 61, Issue:8 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lomustine; Melphalan; Methotrexate; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Prednisone	1977
Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit. British journal of cancer, 1990, Volume: 61, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; Female; Humans; Lomustine; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Vincristine; Vindesine	1990
[Solitary plasmacytoma of the maxillary sinus]. Otolaryngologia polska = The Polish otolaryngology, 1991, Volume: 45, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Humans; Lomustine; Male; Maxillary Sinus Neoplasms; Melphalan; Plasmacytoma; Prednisone	1991
Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine. British journal of cancer, 1990, Volume: 62, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cyclophosphamide; Drug Synergism; Female; Hydralazine; Lomustine; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Sarcoma, Experimental; Stem Cells	1990
[Various doses cisplatin combined with multi-drug chemotherapy of malignant solid tumors]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1989, Volume: 11, Issue:3 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Melphalan; Methotrexate; Middle Aged; Neoplasms; Procarbazine; Testicular Neoplasms; Vincristine	1989
Improved long-term survival in multiple myeloma. Finnish Leukaemia Group. European journal of haematology, 1989, Volume: 43, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Finland; Humans; Lomustine; Melphalan; Methylprednisolone; Multiple Myeloma; Prognosis; Remission Induction; Survival Analysis; Time Factors; Vincristine	1989
Adults with Ewing's sarcoma. An analysis of 16 patients at the Dana-Farber Cancer Institute. American journal of clinical oncology, 1988, Volume: 11, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Lomustine; Male; Melphalan; Middle Aged; Prednisone; Prognosis; Sarcoma, Ewing; Vincristine; Vindesine	1988
Stimulatory and suppressive effects of anti-cancer drugs and X-irradiation on the production of interleukin-2 by murine lymphoid cells. Immunopharmacology, 1986, Volume: 11, Issue:1 Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Female; Interleukin-2; Lomustine; Lymphocytes; Male; Melphalan; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Spleen; X-Rays	1986
[Combined chemotherapy in advanced stages of chronic lymphatic leukemia]. Vnitrni lekarstvi, 1987, Volume: 33, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Lymphoid; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Prednisone	1987
CB 1954 revisited. II. Toxicity and antitumour activity. Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:1 Topics: Animals; Aziridines; Azirines; Colonic Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Humans; Lomustine; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Sarcoma, Experimental	1986
Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo. British journal of cancer, 1986, Volume: 53, Issue:2 Topics: Animals; Carmustine; Cell Line; Cell Survival; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Resistance; Lomustine; Lung Neoplasms; Melphalan; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Nitrosourea Compounds; Semustine; Time Factors	1986
Thermochemotherapy with cis-platinum, CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: therapeutic gain for melphalan only. The British journal of radiology, 1985, Volume: 58, Issue:685 Topics: Animals; Antineoplastic Agents; Bone Marrow; Carmustine; Chlorambucil; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Hyperthermia, Induced; Lomustine; Melphalan; Mice; Mice, Inbred C3H; Neoplasms, Experimental	1985
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV). Cancer chemotherapy and pharmacology, 1983, Volume: 11, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine	1983
[Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases]. Presse medicale (Paris, France : 1983), 1983, Apr-30, Volume: 12, Issue:19 Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Time Factors; Vincristine	1983
Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse. British journal of cancer, 1983, Volume: 47, Issue:1 Topics: Amifostine; Animals; Antineoplastic Agents; Chlorambucil; Cisplatin; Cyclophosphamide; Female; Leukocyte Count; Lomustine; Male; Melphalan; Mice; Mice, Inbred C3H; Organothiophosphorus Compounds; Sarcoma, Experimental	1983
Modification of alkylating agent cytotoxicity by cisplatin. International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:9 Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Lomustine; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental	1984
Amphotericin B potentiation of the cytotoxicity of anticancer agents against both normal hematopoietic and leukemia cells in mice. Journal of the National Cancer Institute, 1984, Volume: 73, Issue:2 Topics: Amphotericin B; Animals; Antineoplastic Agents; Cell Survival; Doxorubicin; Drug Synergism; Hematopoietic Stem Cells; Leukemia L1210; Leukemia, Experimental; Lomustine; Melphalan; Mice; Mice, Inbred AKR; Mice, Inbred Strains	1984
[Combination chemotherapy with vincristine, melphalan, CCNA, cyclophosphamide, prednisone in myeloma]. Revue du rhumatisme et des maladies osteo-articulaires, 1984, Volume: 51, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; France; Humans; Lomustine; Male; Melphalan; Multiple Myeloma; Prednisone; Prospective Studies; Vincristine	1984
Response to X-radiation and cytotoxic drugs of clonal subpopulations of different ploidy and metastatic potential isolated from RIF-1 mouse sarcoma. British journal of cancer, 1983, Volume: 47, Issue:6 Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Clone Cells; Dose-Response Relationship, Drug; Doxorubicin; Lomustine; Melphalan; Mice; Mice, Inbred C3H; Ploidies; Sarcoma, Experimental	1983
Chemosensitization by lipophilic nitroimidazoles. British journal of cancer, 1983, Volume: 48, Issue:1 Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Leukocyte Count; Lomustine; Male; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Time Factors	1983
In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids. British journal of cancer, 1982, Volume: 46, Issue:6 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Aggregation; Cell Division; Cell Line; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Melphalan; Mice; Neoplasm Transplantation; Neoplasms; Ovarian Neoplasms; Transplantation, Heterologous; Vinca Alkaloids	1982
Response of two mouse tumours to hyperthermia with CCNU or melphalan. British journal of cancer, 1982, Volume: 45, Issue:1 Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Hot Temperature; Lomustine; Lung Neoplasms; Male; Melanoma; Melphalan; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nitrosourea Compounds; Temperature; Time Factors	1982
Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU. British journal of cancer, 1982, Volume: 45, Issue:3 Topics: Animals; Antineoplastic Agents; Cell Survival; Chlorambucil; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Lethal Dose 50; Leukocyte Count; Lomustine; Male; Melphalan; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental	1982
Chemotherapy of hormone-resistant stage D prostatic cancer. The Journal of urology, 1980, Volume: 123, Issue:6 Topics: Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Estramustine; Fluorouracil; Humans; Hydroxyurea; Lomustine; Male; Melphalan; Methotrexate; Prednimustine; Prostatic Neoplasms	1980
The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy. Leukemia & lymphoma, 1994, Volume: 13, Issue:1-2 Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lomustine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melphalan; Methotrexate; Middle Aged; Phosphoramide Mustards; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Vincristine	1994
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Pancytopenia; Prednisone; Procarbazine; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine; Vincristine	1994
Effects of various antineoplastic agents on an established human melanoma cell line (G-361). Histology and histopathology, 1995, Volume: 10, Issue:1 Topics: Anisoles; Antineoplastic Agents; Cell Division; Cell Line; Cell Survival; Drug Screening Assays, Antitumor; Humans; Lomustine; Melanocytes; Melanoma; Melphalan; Microscopy, Electron; Tumor Cells, Cultured	1995
Prognostic value of plasma-cell immunophenotype in patients with multiple myeloma. Neoplasma, 1993, Volume: 40, Issue:6 Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; HLA-DR Antigens; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin Isotypes; Immunophenotyping; Lomustine; Longitudinal Studies; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Plasma Cells; Prednisone; Prognosis; Regression Analysis; Survival Analysis; Vincristine	1993
Azelaic acid was sensitizing effect in the chemotherapeutic treatment of several melanoma cell lines. Pigment cell research, 1996, Volume: 9, Issue:6 Topics: Animals; Anisoles; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cell Differentiation; Cell Division; Dicarboxylic Acids; Dose-Response Relationship, Drug; Drug Synergism; Humans; Lomustine; Melanoma; Melphalan; Mice; Microscopy, Electron, Scanning; Monophenol Monooxygenase; Tumor Cells, Cultured; Vacuoles	1996
The effects of different antineoplastic agents and of pretreatment by modulators on three melanoma lines. Cancer, 1998, Feb-01, Volume: 82, Issue:3 Topics: Animals; Anisoles; Antineoplastic Agents; Buthionine Sulfoximine; Dicarboxylic Acids; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Ethacrynic Acid; Humans; In Vitro Techniques; Lomustine; Melanoma, Experimental; Melphalan; Mice; Monophenol Monooxygenase; Nitrosourea Compounds; Organophosphorus Compounds; Tumor Cells, Cultured	1998
The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients. Bone marrow transplantation, 1999, Volume: 23, Issue:1 Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Combined Modality Therapy; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Transplantation, Autologous	1999
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. British journal of cancer, 1999, Volume: 81, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine	1999
Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cells in vitro and in xenografts. International journal of cancer, 2000, Feb-15, Volume: 85, Issue:4 Topics: Adenosine Triphosphatases; Animals; Base Pair Mismatch; Burkitt Lymphoma; Cell Division; Cross-Linking Reagents; DNA Repair Enzymes; DNA-Binding Proteins; HeLa Cells; Humans; Lomustine; Melphalan; Mice; Mice, Knockout; Mice, Nude; Micronucleus Tests; Mismatch Repair Endonuclease PMS2; Mitomycin; MutS Homolog 2 Protein; Proteins; Proto-Oncogene Proteins; Transplantation, Heterologous; Tumor Cells, Cultured	2000
Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma. Cancer chemotherapy and pharmacology, 2001, Volume: 47 Suppl Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chymotrypsin; Cohort Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Combinations; Endopeptidases; Female; Humans; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Papain; Prednisone; Proportional Hazards Models; Retrospective Studies; Survival Rate; Trypsin; Vincristine	2001
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma. European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:4 Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Mesna; Neuroblastoma; Pilot Projects; Risk Factors; Thoracic Neoplasms; Topotecan; Treatment Outcome	2011
Anaplastic atypical myeloma with extensive cutaneous involvement in a dog. The Journal of veterinary medical science, 2012, Volume: 74, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Fatal Outcome; Lomustine; Male; Melphalan; Multiple Myeloma; Prednisolone; Skin Neoplasms	2012
Modified BEAM conditioning regimen in patients with Hodgkin and non-Hodgkin lymphomas. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2012, Volume: 10, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Lymphoma, Non-Hodgkin; Melphalan	2012
Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose. Bone marrow transplantation, 2014, Volume: 49, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Melphalan; Middle Aged; Transplantation Conditioning; Young Adult	2014
LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy. International journal of hematology, 2016, Volume: 103, Issue:3 Topics: Adolescent; Adult; Autografts; Carmustine; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multicenter Studies as Topic; Retrospective Studies; Survival Rate; Transplantation Conditioning; Young Adult	2016
A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM. Bone marrow transplantation, 2016, Volume: 51, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Melphalan; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous	2016
Canine Cutaneous Plasmacytosis: 21 Cases (2005-2015). Journal of veterinary internal medicine, 2017, Volume: 31, Issue:4 Topics: Animals; Antineoplastic Agents, Alkylating; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Lomustine; Male; Melphalan; Plasmacytoma; Prednisone; Skin; Skin Neoplasms	2017
Substituting carmustine for lomustine is safe and effective in the treatment of relapsed or refractory Lymphoma-a retrospective study from the BSBMT (BEAM versus LEAM). Bone marrow transplantation, 2021, Volume: 56, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Humans; Lomustine; Lymphoma; Melphalan; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous	2021